Insiders · Profile

Spragens Jeffrey G

Director at SAB Biotherapeutics. Filing since 1 Oct 2021. CIK 0001410620

Company

Date

Role

Action

Shares

Amount

Of holding

SABS SAB Biotherapeutics, Inc.

1 Oct 2021

Director

Bought

13,000

$130.91K

opened

1 decision on file.